Cocrystal Pharma, Inc.
COCP
$1.02
$0.010.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.29% | 49.55% | 48.29% | 29.94% | 5.38% |
| Total Depreciation and Amortization | -151.72% | -101.59% | -90.58% | -99.57% | -86.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.27% | -53.92% | -53.31% | -7.68% | 4.72% |
| Change in Net Operating Assets | 378.84% | 110.00% | -130.90% | -150.64% | 197.93% |
| Cash from Operations | 49.11% | 50.31% | 42.25% | 5.86% | 7.08% |
| Capital Expenditure | -- | -50.00% | 82.09% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -50.00% | 82.09% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.01% | 82.81% | 68.35% | 6.30% | -22.92% |